| Degarelix Superior to Leuprolide, Study Finds - Renal and Urology News |
|
|
Renal and Urology News “The long-term data support the durability of the significant progression-free survival benefit for degarelix treatment over monthly leuprolide seen during the first treatment year,” Dr. Shore told Renal & Urology News. Additionally, he noted, these |